WPRIM Management System> DCMS> Journal of Gynecologic Oncology> 2022> 33> 2

Volume: 33 Issue: 2

1. Major clinical research advances in gynecologic cancer in 2021 Page:e43—
2. Informed consent forms for gynecologic cancer surgery: recommendations from the Korean Society of Gynecologic Oncology Page:e42—
3. Conditional relative survival of patients with endometrial cancer: a Korean National Cancer Registry study Page:e23—
4. Protective ostomies in ovarian cancer surgery: a systematic review and meta-analysis Page:e21—
5. The 7th Biennial Meeting of the Asian Society of Gynecologic Oncology, November 25th to 27th, 2021 Page:e36—
6. A prospective comparison of the diagnostic accuracies of ultrasound and magnetic resonance imaging in preoperative staging of endometrial cancer Page:e22—
7. Novel vaginoplasty technique involving the use of peritoneal flaps during laparoscopic radical hysterectomy for early-stage cervical cancer Page:e19—
8. A single-arm, phase II study of niraparib and bevacizumab maintenance therapy in platinum-sensitive, recurrent ovarian cancer patients previously treated with a PARP inhibitor: Korean Gynecologic Oncology Group (KGOG 3056)/NIRVANA-R trial Page:e12—
9. Prognosis in primary mucinous ovarian carcinoma: focusing on the five pathological findings indicating metastatic mucinous carcinoma to the ovary Page:e18—
10. Clinical evaluation of a droplet digital PCR assay for detecting POLE mutations and molecular classification of endometrial cancer Page:e15—
11. Comparison of treatment outcomes of surgery and radiotherapy, including concurrent chemoradiotherapy for stage Ib2-IIb cervical adenocarcinoma patients: a retrospective study Page:e14—
12. An evaluation of prognostic factors, oncologic outcomes, and management for primary and recurrent squamous cell carcinoma of the vulva Page:e13—
13. One-step nucleic acid amplification (OSNA) assay for detecting lymph node metastasis in cervical and endometrial cancer: a preliminary study Page:e11—